Literature DB >> 17323057

Genetic polymorphisms of folate metabolic enzymes and toxicities of high dose methotrexate in children with acute lymphoblastic leukemia.

Samart Pakakasama, Kittima Kanchanakamhaeng, Saowanee Kajanachumpol, Umaporn Udomsubpayakul, Nongnuch Sirachainan, Amnuay Thithapandha, Suradej Hongeng.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17323057     DOI： 10.1007/s00277-007-0274-x

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  9 in total

1.  PharmGKB summary: methotrexate pathway.

Authors:  Torben S Mikkelsen; Caroline F Thorn; Jun J Yang; Cornelia M Ulrich; Deborah French; Gianluigi Zaza; Henry M Dunnenberger; Sharon Marsh; Howard L McLeod; Kathy Giacomini; Mara L Becker; Roger Gaedigk; James Steven Leeder; Leo Kager; Mary V Relling; William Evans; Teri E Klein; Russ B Altman
Journal:  Pharmacogenet Genomics       Date:  2011-10       Impact factor: 2.089

Review 2.  Gene polymorphisms in the folate metabolism and their association with MTX-related adverse events in the treatment of ALL.

Authors:  Yang Chen; Zuojun Shen
Journal:  Tumour Biol       Date:  2015-05-30

3.  Impact of methylenetetrahydrofolate reductase (MTHFR) polymorphisms on methotrexate-induced toxicities in acute lymphoblastic leukemia: a meta-analysis.

Authors:  Lin Yang; Xin Hu; Luhang Xu
Journal:  Tumour Biol       Date:  2012-04-20

Review 4.  Pharmacogenetics predictive of response and toxicity in acute lymphoblastic leukemia therapy.

Authors:  Lin Mei; Evelena P Ontiveros; Elizabeth A Griffiths; James E Thompson; Eunice S Wang; Meir Wetzler
Journal:  Blood Rev       Date:  2015-01-10       Impact factor: 8.250

5.  Gene polymorphisms in folate metabolizing enzymes in adult acute lymphoblastic leukemia: effects on methotrexate-related toxicity and survival.

Authors:  Alessia Ongaro; Monica De Mattei; Matteo Giovanni Della Porta; GianMatteo Rigolin; Cristina Ambrosio; Francesco Di Raimondo; Agnese Pellati; Federica Francesca Masieri; Angelo Caruso; Linda Catozzi; Donato Gemmati
Journal:  Haematologica       Date:  2009-07-31       Impact factor: 9.941

Review 6.  Pharmacogenetics of methotrexate in acute lymphoblastic leukaemia: why still at the bench level?

Authors:  Sunitha Kodidela; Pradhan Suresh Chandra; Biswajit Dubashi
Journal:  Eur J Clin Pharmacol       Date:  2013-12-27       Impact factor: 2.953

Review 7.  Pharmacogenomics in Pediatric Oncology: Review of Gene-Drug Associations for Clinical Use.

Authors:  Vid Mlakar; Patricia Huezo-Diaz Curtis; Chakradhara Rao Satyanarayana Uppugunduri; Maja Krajinovic; Marc Ansari
Journal:  Int J Mol Sci       Date:  2016-09-08       Impact factor: 5.923

8.  Influence of Methylenetetrahydrofolate Reductase C677T, A1298C, and G80A Polymorphisms on the Survival of Pediatric Patients with Acute Lymphoblastic Leukemia.

Authors:  Dayse Maria Vasconcelos de Deus; Elker Lene Santos de Lima; Rafaela Maria Seabra Silva; Edinalva Pereira Leite; Maria Tereza Cartaxo Muniz
Journal:  Leuk Res Treatment       Date:  2012-10-17

9.  Influence of Folate-Related Gene Polymorphisms on High-Dose Methotrexate-Related Toxicity and Prognosis in Turkish Children with Acute Lymphoblastic Leukemia.

Authors:  Burcu Yazıcıoğlu; Zühre Kaya; Sezen Güntekin Ergun; Ferda Perçin; Ülker Koçak; İdil Yenicesu; Türkiz Gürsel
Journal:  Turk J Haematol       Date:  2016-04-18       Impact factor: 1.831
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.